doi: 10.1016/j.ejphar.2016.04.052 165 HolstJJBurcelinRNathansonE
by Summer Kessel, RD, CSOWM, LDN Spring 2025 If youre using a GLP-1 medication for obesity treatment, youve probably noticed changes in your appetite, digestion and even how you think about food
Before starting any GLP-1 medication, patients should undergo thorough medical evaluations to ensure these drugs are appropriate for their health conditions
Mechanism of Action (Research Context) In controlled research environments, retatrutide has been shown to interact with three key metabolic signalling pathways: GLP-1 receptor activity associated with appetite signalling and glucose regulation GIP receptor activity involved in insulin and fat metabolism Glucagon receptor activity linked to energy expenditure and lipid mobilisation This triple-pathway engagement makes retatrutide of particular interest for metabolic and endocrine research models studying obesity, insulin resistance and energy homeostasis
People have long struggled with eating temptations, but with the advent of smartphone apps that allow us to order pizza or wings for delivery with a single tap, its much more difficult to resist these cravings these days
"We know from the Diabetes Prevention Program that yes, if we improve weight without medication, if they're able to improve it by 5% to 7%, even that smaller amount of weight does improve people's different chronic conditions," Alexander explained
